Table of Contents

1. Introduction

 1.1 Precision Medicine Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Precision Medicine Market Snapshot

 2.2 Precision Medicine Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Precision Medicine Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Precision Medicine Market Size By Type

  2.3.2 Precision Medicine Market Size By Technology

  2.3.3 Precision Medicine Market Size By Application

  2.3.4 Precision Medicine Market Size By End User

 2.4 Precision Medicine Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Precision Medicine Market Overview

 3.1 Precision Medicine Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Precision Medicine Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Precision Medicine Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers (Reagents, Kits, Instruments)

  3.4.2 Manufacturers (Sequencing Platforms, Diagnostic Tools)

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users (Hospitals, Labs, Research Institutes)

 3.5 Industry Life Cycle Assessment

 3.6 Parent Precision Medicine Market Overview

 3.7 Precision Medicine Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Pricing Analysis & Forecast

  4.1.1 Overview

  4.1.2 Average Cost of Whole Genome Sequencing vs. Targeted Panels

  4.1.3 Reimbursement Landscape for Companion Diagnostics & Genetic Tests

  4.1.4 Regional Pricing Variations for NGS and Genomic Profiling

  4.1.5 Emerging Pricing Models (Subscription-based Genomic Testing, Value-based Reimbursement)

4.2 Regulatory & Compliance Landscape

  4.2.1 Overview

  4.2.2 FDA Approvals & Breakthrough Device Designations for Precision Medicine Tools

  4.2.3 Compliance with CLIA, CAP, and IVDR Regulations for Diagnostic Labs

  4.2.4 Data Privacy Laws (GDPR, HIPAA, GINA) Impacting Genomic Data Sharing

  4.2.5 Strategic Guidelines for Regulatory Approval of AI-based Diagnostic Algorithms

4.3 Technology & Innovation Metrics

  4.3.1 Overview

  4.3.2 Adoption Rate of Next-Generation Sequencing (NGS) vs. Traditional PCR Methods

  4.3.3 Investment in CRISPR-based Therapies and Gene Editing Platforms

  4.3.4 Patent Filings and Technological Innovations in Liquid Biopsy & Multi-omics

  4.3.5 Emerging Trends: AI-driven Biomarker Discovery, Single-cell Sequencing, and Wearable-integrated Diagnostics

4.4 Operational & Clinical Adoption Metrics

  4.4.1 Overview

  4.4.2 Number of Precision Medicine Tests Performed Annually by Region

  4.4.3 Turnaround Time for Genomic Profiling Results in Clinical Settings

  4.4.4 Patient Enrollment Rates in Biomarker-driven Clinical Trials

  4.4.5 Laboratory Accreditation Rates and Quality Control Benchmarks

4.5 Investment & Strategic Activity

  4.5.1 Overview

  4.5.2 Venture Capital and Private Equity Investments in Precision Medicine Startups

  4.5.3 Key M&A Activity and Strategic Partnerships (Pharma-Biotech, Diagnostic Companies)

  4.5.4 Collaborations Between Academic Research Centers, Hospitals, and Genomic Platforms

  4.5.5 Emerging Innovation Hubs and R&D Centers for Precision Oncology and Rare Diseases

5. Precision Medicine Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Targeted Therapy

  5.2.1 Key Trends

  5.2.2 Precision Medicine Market Size & Forecast, 2022–2035

 5.3 Genomic Medicine

 5.4 Pharmacogenomics

 5.5 Companion Diagnostics

 5.6 Others

6. Precision Medicine Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Next-Generation Sequencing (NGS)

  6.2.1 Key Trends

  6.2.2 Precision Medicine Market Size & Forecast, 2022–2035

 6.3 PCR & qPCR

 6.4 CRISPR

 6.5 Bioinformatics

 6.6 Others

7. Precision Medicine Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Oncology

  7.2.1 Key Trends

  7.2.2 Precision Medicine Market Size & Forecast, 2022–2035

 7.3 Cardiovascular Diseases

 7.4 Rare & Genetic Disorders

 7.5 Neurological Disorders

 7.6 Others

8. Precision Medicine Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Precision Medicine Market Size & Forecast, 2022–2035

 8.3 Diagnostic Laboratories

 8.4 Research Institutes

 8.5 Pharmaceutical & Biotech Companies

9. Precision Medicine Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Precision Medicine Market Size & Forecast, By Type, 2022–2035

 9.2.3 Precision Medicine Market Size & Forecast, By Technology, 2022–2035

 9.2.4 Precision Medicine Market Size & Forecast, By Application, 2022–2035

 9.2.5 Precision Medicine Market Size & Forecast, By End User, 2022–2035

 9.2.6 Precision Medicine Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Precision Medicine Market Size & Forecast, By Type, 2022–2035

 9.3.3 Precision Medicine Market Size & Forecast, By Technology, 2022–2035

 9.3.4 Precision Medicine Market Size & Forecast, By Application, 2022–2035

 9.3.5 Precision Medicine Market Size & Forecast, By End User, 2022–2035

 9.3.6 Precision Medicine Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Precision Medicine Market Size & Forecast, By Type, 2022–2035

 9.4.3 Precision Medicine Market Size & Forecast, By Technology, 2022–2035

 9.4.4 Precision Medicine Market Size & Forecast, By Application, 2022–2035

 9.4.5 Precision Medicine Market Size & Forecast, By End User, 2022–2035

 9.4.6 Precision Medicine Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Precision Medicine Market Size & Forecast, By Type, 2022–2035

 9.5.3 Precision Medicine Market Size & Forecast, By Technology, 2022–2035

 9.5.4 Precision Medicine Market Size & Forecast, By Application, 2022–2035

 9.5.5 Precision Medicine Market Size & Forecast, By End User, 2022–2035

 9.5.6 Precision Medicine Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Precision Medicine Market Size & Forecast, By Type, 2022–2035

 9.6.3 Precision Medicine Market Size & Forecast, By Technology, 2022–2035

 9.6.4 Precision Medicine Market Size & Forecast, By Application, 2022–2035

 9.6.5 Precision Medicine Market Size & Forecast, By End User, 2022–2035

 9.6.6 Precision Medicine Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Precision Medicine Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

10.6.1 Illumina

 10.6.1.1 Company Overview & Snapshot

 10.6.1.2 Product/Service Portfolio

 10.6.1.3 Key Company Financials

 10.6.1.4 SWOT Analysis

10.6.2 Thermo Fisher Scientific

10.6.3 Roche

10.6.4 Pfizer

10.6.5 Novartis

10.6.6 AstraZeneca

10.6.7 Johnson & Johnson

10.6.8 Merck & Co.

10.6.9 Abbott Laboratories

10.6.10 Medtronic

10.6.11 Qiagen

10.6.12 Guardant Health

10.6.13 Myriad Genetics

10.6.14 Foundation Medicine

10.6.15 Tempus Labs

10.6.16 Caris Life Sciences

10.6.17 Exact Sciences

10.6.18 Agilent Technologies

10.6.19 Siemens Healthineers

10.6.20 23andMe

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Precision Medicine Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Precision Medicine Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures